In the most recent trading session, Oscar Health, Inc. (OSCR) closed at $16.28, indicating a -0.12% shift from the previous trading day.
In the latest trading session, Oscar Health, Inc. (OSCR) closed at $15.65, marking a -1.57% move from the previous day.
Oscar Health's targets of a 20% revenue CAGR through 2027 and 5% operating margin imply operating income around $700m in 3 years. Despite not being profitable yet, Oscar Health is projected to achieve GAAP profitability in FY24, with EPS expected to grow to $0.51 by FY25. The key risk is the repeal of ACA by the Trump administration, which would significantly impact the affordability of health insurance premiums for individual buyers.
The latest trading day saw Oscar Health, Inc. (OSCR) settling at $14.17, representing a -0.07% change from its previous close.
In the most recent trading session, Oscar Health, Inc. (OSCR) closed at $13.44, indicating a -1.03% shift from the previous trading day.
The latest trading day saw Oscar Health, Inc. (OSCR) settling at $13.58, representing a -1.59% change from its previous close.
The latest trading day saw Oscar Health, Inc. (OSCR) settling at $13.50, representing a +0.9% change from its previous close.
Mark Bertolini, Oscar Health CEO and former Aetna chairman and CEO, joins 'Squawk Box' to discuss the state of the health insurance industry in the wake of the killing of UnitedHealthcare CEO Brian Thompson, public anger over insurance claim denials, what can be done to fix the health care system, and more.
After UnitedHealthcare (UNH) CEO Brian Thompson was fatally shot in New York City last week, various health insurance providers have removed executives' biography pages from the corporate websites. NYPD investigators have found this shooting to be "a pre-meditated, pre-planned, targeted attack" as the manhunt for the assailant continues.
Mark Bertolini, Oscar Health CEO, joins 'Squawk Box' to discuss what the new administration means for the health care sector, ways to roll back parts of Obamacare, and much more.
Oscar Health (OSCR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Start Time: 08:00 January 1, 0000 8:36 AM ET Oscar Health, Inc. (NYSE:OSCR ) Q3 2024 Earnings Call November 07, 2024, 08:00 AM ET Company Participants Mark Bertolini - CEO Scott Blackley - Chief Financial Officer Chris Potochar - VP, Treasury and IR Conference Call Participants Stephen Baxter - Wells Fargo John Ransom - Raymond James Jessica Tassan - Piper Sandler Joshua Raskin - Nephron Research Michael Ha - Baird Adam Ron - Bank of America Operator Good morning. My name is Angela, and I will be your conference operator today.